Biologic therapy for psoriasis: The tumor necrosis factor inhibitors - Infliximab and etanercept

This article has been peer reviewed and approved,by Michael Fisher, MD, Professor of Medicine, Albert Einstein College of Medicine Review date December 2002, December. This activity has been planned and implemented in accordance with the Essential Area's and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship, of Albert Einstein College of Medicine and :Quadrant HealthCom, Inc. The Albert Einstein College of Medicine is accredited by the ACCME to provide continuing medical education for physicians. Albert Einstein College of Medicine designates this educational activity for a in category, 1 credit toward the AMA Physician's Recognition. Award. Each physician should claim only those hours of credit that he/she actually spent in the educational activity. This activity has been planned and produced in accordance with ACCME Essentials.